BR112018067999A2 - composições compreendendo ácidos graxos e seu uso - Google Patents

composições compreendendo ácidos graxos e seu uso

Info

Publication number
BR112018067999A2
BR112018067999A2 BR112018067999A BR112018067999A BR112018067999A2 BR 112018067999 A2 BR112018067999 A2 BR 112018067999A2 BR 112018067999 A BR112018067999 A BR 112018067999A BR 112018067999 A BR112018067999 A BR 112018067999A BR 112018067999 A2 BR112018067999 A2 BR 112018067999A2
Authority
BR
Brazil
Prior art keywords
potential
compositions
fatty acids
composition
female individual
Prior art date
Application number
BR112018067999A
Other languages
English (en)
Inventor
Silva Zolezzi Irma
HAUSER Jonas
Schneider Nora
DEONI Sean
Bartfai Tamas
Mary Samuel Tinu
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BR112018067999A2 publication Critical patent/BR112018067999A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Ink Jet (AREA)

Abstract

a presente invenção refere-se a uma composição que compreende um ou mais derivados de ácido graxo para uso na promoção, no suporte ou na otimização de um ou mais dos seguintes: (i) remielinização; (ii) estrutura cerebral; (iii) conectividade cerebral; (iv) potencial intelectual; (v) potencial cognitivo; e (vi) potencial de aprendizagem; (vii) funcionamento cognitivo em uma prole de um indivíduo do sexo feminino, sendo que a dita composição é para administração ao indivíduo do sexo feminino.
BR112018067999A 2016-03-30 2017-03-30 composições compreendendo ácidos graxos e seu uso BR112018067999A2 (pt)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201662315152P 2016-03-30 2016-03-30
US201662315142P 2016-03-30 2016-03-30
US201662315134P 2016-03-30 2016-03-30
US201662315158P 2016-03-30 2016-03-30
US201662315163P 2016-03-30 2016-03-30
US201662328094P 2016-04-27 2016-04-27
PCT/EP2016/080786 WO2017167415A1 (en) 2016-03-30 2016-12-13 Compositions comprising fatty acids and their use
PCT/EP2017/057576 WO2017167899A1 (en) 2016-03-30 2017-03-30 Compositions comprising fatty acids and their use

Publications (1)

Publication Number Publication Date
BR112018067999A2 true BR112018067999A2 (pt) 2019-01-15

Family

ID=57614346

Family Applications (2)

Application Number Title Priority Date Filing Date
BR112018011412A BR112018011412A2 (pt) 2016-03-30 2016-12-13 composições que compreendem ácidos graxos e seu uso
BR112018067999A BR112018067999A2 (pt) 2016-03-30 2017-03-30 composições compreendendo ácidos graxos e seu uso

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BR112018011412A BR112018011412A2 (pt) 2016-03-30 2016-12-13 composições que compreendem ácidos graxos e seu uso

Country Status (8)

Country Link
EP (2) EP3984532A3 (pt)
CN (2) CN108495627A (pt)
BR (2) BR112018011412A2 (pt)
CA (2) CA3003651A1 (pt)
MX (3) MX2018008520A (pt)
PH (2) PH12018501027A1 (pt)
SG (2) SG11201803022TA (pt)
WO (2) WO2017167415A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3643179A1 (en) * 2018-09-13 2020-04-29 Original Biological Technology Co., Ltd. Nutritional formula milk powder for congenital heart disease surgery and non-cardiac surgery and other intensive care infants, and use method thereof
CN109805390A (zh) * 2019-02-27 2019-05-28 云南大学 一种神经酸钙、神经酸锌及维生素k2复合物软胶囊
CN110946099A (zh) * 2019-12-13 2020-04-03 宁波大学 一种提高双壳贝类苗种繁育产量的方法
CN113508840A (zh) * 2020-04-09 2021-10-19 北京三元食品股份有限公司 乳脂球膜在制备孕妇奶粉中的应用
CN114544821B (zh) * 2020-11-24 2023-10-24 重庆医科大学 检测血浆中磷脂酰乙醇胺（36:4）的试剂在制备抑郁症检测试剂盒中的用途
WO2024038010A1 (en) 2022-08-18 2024-02-22 Société des Produits Nestlé S.A. Kit to promote developmental myelination
CN116008438B (zh) * 2023-02-07 2023-06-06 北京三元食品股份有限公司 一种用于评价婴幼儿精细动作发育状况的标志物组及应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0322589B1 (fr) 1987-12-23 1993-01-20 Societe Des Produits Nestle S.A. Procédé de préparation d'un hydrolysat de protéines de lactosérum et d'un aliment hypoallergéniques
GB9416846D0 (en) * 1994-08-19 1994-10-12 Croda Int Plc Lipid supplementation
EP0880902A1 (fr) 1997-05-27 1998-12-02 Nestlé Produkte AG Procédé de traitement d'une matiére première lactosérique
AU4555799A (en) * 1998-06-12 1999-12-30 Craig Anthony Cooney Nutritional methyl supplements change epigenetics, dna methylation, phenotype, and appearance of mammalian offspring
CN100413423C (zh) 1999-04-29 2008-08-27 雀巢制品公司 用于具有低苏氨酸含量的婴儿配制食品的组合物
WO2003017945A2 (en) * 2001-08-24 2003-03-06 Martek Biosciences Boulder Corporation Products containing highly unsaturated fatty acids for use by women and their children during stages of preconception, pregnancy and lactation/post-partum
MX2007011046A (es) * 2005-03-10 2007-11-14 Sciele Pharma Inc Preparaciones nutritivas.
EP1898722B1 (en) * 2005-04-28 2013-04-10 Enzymotec Ltd. Polar lipid mixtures, their preparation and uses
AU2006251569B2 (en) * 2005-05-23 2012-06-21 Massachusetts Institute Of Technology Compostions containing pufa and/or uridine and methods of use thereof
KR101430214B1 (ko) * 2006-12-28 2014-08-18 산토리 홀딩스 가부시키가이샤 신경 재생제
EP2110027A1 (en) * 2008-04-01 2009-10-21 Nestec S.A. Long-chain polyunsaturated fatty acids (LC-PUFA) in maternal nutrition during pregnancy and lactation
EP2454948A1 (en) 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula

Also Published As

Publication number Publication date
EP3984532A2 (en) 2022-04-20
CN108778265A (zh) 2018-11-09
MX2022014683A (es) 2023-01-11
WO2017167415A1 (en) 2017-10-05
BR112018011412A2 (pt) 2018-12-04
PH12018550141A1 (en) 2019-03-11
CA3015028A1 (en) 2017-10-05
WO2017167899A1 (en) 2017-10-05
SG11201803022TA (en) 2018-05-30
EP3435997A1 (en) 2019-02-06
MX2018008520A (es) 2018-08-16
EP3984532A3 (en) 2022-09-21
PH12018501027A1 (en) 2019-01-28
CA3003651A1 (en) 2017-10-05
CN108495627A (zh) 2018-09-04
SG11201806545WA (en) 2018-10-30
MX2018011336A (es) 2019-01-31

Similar Documents

Publication Publication Date Title
BR112018067999A2 (pt) composições compreendendo ácidos graxos e seu uso
BR112018010335A2 (pt) composição nutricional e fórmula para bebês para promover mielinização do cérebro
BR112018067423A2 (pt) composições que compreendem colina e uso das mesmas
CL2018001089A1 (es) Sales de valbenazina y polimorfos de las mismas.
BR112014008944A2 (pt) composição para uso no crescimento cerebral e/ou desenvolvimento cognitivo e/ou psicomotor
BR112015024647A2 (pt) fórmula para bebês com um baixo teor de mcfas em proporções específicas e um teor relativamente alto de ácidos graxos insaturados, e seu uso na promoção do estabelecimento saudável da função cognitiva em bebês
BR112018017350A2 (pt) composições que compreendem fosfolipídeo e seu uso
BR112015020772A2 (pt) compostos de pirimidina e piridina e seu uso
BR112014014184A2 (pt) triazolopiridinas substituídas e seu uso como inibidores de ttk
BR112014018421A8 (pt) Composições antimicrobianas compreendendo dgla, 15-ohepa e/ou 15-hetre e métodos de uso das mesmas
BR112017003346A2 (pt) derivados de pirazolopiridina, seus usos, e composição farmacêutica
BR112015018491A2 (pt) triterpenoides c-19-modificados com atividade inibidora de maturação de hiv
BR112017007375A2 (pt) composição compreendendo oligossa¬carídeos fut2 dependentes e lacto-n-neotetraose para uso na promoção do desenvolvimento e da cognição cerebral
BR112016011170A8 (pt) derivados de heteroaril ácido butanoico, seus usos, combinação e composição farmacêutica
BR112018067730A2 (pt) composições que compreendem minerais e seu uso
BR112019006023A2 (pt) forma cristalina, métodos de preparação da forma cristalina e do composto, composição farmacêutica, e, métodos para tratar ou prevenir uma doença ou enfermidade e para modular atividade de cinase.
BR112018068369A2 (pt) composições e uso das mesmas
BR112015021649A2 (pt) fórmula para bebês com um baixo teor de ácidos graxos de cadeia média em proporções específicas, e o uso da mesma para promover e/ou assegurar um crescimento equilibrado de bebês
BR112016021471A8 (pt) derivados de ácido acético azaindol e seu uso como moduladores de receptor d2 de prosrtglandina
WO2017167898A3 (en) Compositions comprising vitamins and their use
CL2018001604A1 (es) Composición nutricional y fórmula infantil para promover la mielinización del cerebro
BR112015017768A2 (pt) compostos
BR102014030351A8 (pt) composição dermatológica e seu uso
BR112016021443A8 (pt) Derivados de ácido acético azaindol e seu uso como moduladores de receptor de prostaglandina d2
BR112015020566A2 (pt) moduladres de ror gama

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: SOCIETE DES PRODUITS NESTLE S.A. (CH)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]